The following report is shorter than usual due to the AGM containing very little of substance, highlighting the difficulty a large FTSE company has in running such an event. On Thursday the 7th of May I attended the Annual General Meeting of GlaxoSmithKline Plc at the QEII Conference Centre, London at 2.30pm. The meeting was attended by about 600 shareholders, less than last year, probably due to the general election being on the same day. On my entry to the building I was stopped by representatives of Medecins Sans Frontieres and asked to raise a question in the Q/A session in the AGM - this I thought didn’t bode well for the AGM as I had the feeling the Q/A session was going to get hijacked, as tends to be
...Not a member? Join today
Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:
Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities
Already a member?
Log in to your account to access this content and all of your other ShareSoc membership benefits.